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In This IssueParsing Ciliopathies with Proteomics
PAGE 513
Ciliopathies are often defined as distinct syndromes, but they share overlapping
phenotypes such as cystic kidneys, retinal degeneration, and neural tube
malformation. Sang et al. used a proteomic approach to parse the relationship
between these different symptoms and specific cilia-related processes, such as
cell polarity and signaling. Mapping the interaction network between proteins
involved in several ciliopathies revealed three connected modules each
involved in a particular attribute of ciliopathies. Moreover, proteins detected in
the interaction network led to the identification of two new disease genes.A Fork in the Road for BRCA2
PAGE 529
The breast cancer suppressor BRCA2 is critical for repair of DNA double-strand breaks via homologous recombination.
Schlacher et al. now show that BRCA2 also prevents these lesions from occurring at stalled replication forks by stabilizing
RAD51 nucleoprotein filaments that protect newly synthesized DNA strands from nuclease-mediated degradation. These
findings reveal an unexpected role for BRCA2 in maintaining genomic integrity and suggest a novel mechanism of tumor
suppression.Balancing Act for Chromatin States
PAGE 543
Cells maintain a constant ratio of silent and active rRNA genes. Wittner et al. now show that the balance of open and closed
chromatin states at yeast rRNA genes results from a dynamic equilibrium between transcription-dependent removal and repli-
cation-dependent assembly of nucleosomes, as opposed to stable, inheritable chromatin states at individual loci. Thus, the
opposing effects of replication and transcription can reset chromatin states during each cell cycle.A-DIOL-Down for Multiple Sclerosis
PAGE 584
Microglia control inflammatory responses in the brain, but deregulation of this
response often contributes to neurodegenerative diseases, including multiple
sclerosis (MS). Now, Saijo et al. discover an endogenous pathway in microglia,
anchored by the estrogen receptor b (ERb), which suppresses neuroinflamma-
tion and can inhibit pathologies similar to MS in a mouse model of the disease.
Specifically, the ERb ligand ADIOL triggers the recruitment of the corepressor
complex CtBP to AP-1-dependent promoters, thereby repressing genes that
amplify inflammatory responses and activate pathogenic T cells.Cell 145, May 13, 2011 ª2011 Elsevier Inc. 485
HDACs Make Gluconeogenesis FOX-y
PAGE 607 and PAGE 596
During fasting, the insulin-regulated transcription factor FOXO maintains
energy balance by triggering the expression of catabolic genes. Mihaylova
et al. and Wang et al. now identify class IIa histone deacetylases (HDACs) as
conserved hormone-inducible FOXO coactivators. In the Drosophila fat body
and the mammalian liver, class IIa HDACs translocate to the nucleus in
response to hormonal signaling and deacetylate FOXO to promote transcrip-
tion. Liver-specific depletion of these HDACs reduces blood sugar levels in
mouse models of type II diabetes, suggesting a potential role for HDAC inhibi-
tors as therapies for metabolic disease.A Chromatin Lock on Olfactory Receptors
PAGE 555
Olfactory receptor (OR) genes are transcribed in a monogenic, monoallelic fashion so that each neuron expresses only one of
several thousand alleles. Here, Magklara et al. show that chromatin-mediated silencing—trimethylation of histones H3K9 and
H4K20—establishes the foundation for this selective regulation. The authors show that silencing is established prior to OR
transcription. The findings indicate that heterochromatin marks typically thought to be static are reversed to allow expression
of one OR per neuron.p53 Targets: Not the Usual Suspects
PAGE 571
p53 launches transcriptional programs to both stimulate DNA damage repair and suppress uncontrolled growth. Brady et al.
show that these functions of p53 are distinct, as alleles of p53 that compromise the DNA damage response do not affect p53-
mediated tumor suppression. Surprisingly, most of the annotated p53 target genes are dispensable for tumor suppression,
and the authors identify a small set of previously unrecognized p53 target genes associated with its tumor suppressor func-
tion. The findings may inform therapy designed to block p53-dependent side effects of chemotherapy without impacting p53
tumor suppression.A Hot Flash for Estrogen
PAGE 622
Hah et al. characterize the immediate effects of estrogen signaling on the tran-
scriptome of breast cancer cells. By detecting nascent transcripts, the authors
find that estrogen regulates a quarter of the transcriptome in a rapid, robust,
and unexpectedly transient manner. Estrogen targets include both protein-
coding and noncoding transcripts andmany previously unannotated intergenic
transcripts. The results provide a comprehensive view of the primary transcrip-
tional effects of estrogen and a model for studying rapid signal-dependent
transcription in other systems.Cell 145, May 13, 2011 ª2011 Elsevier Inc. 487
